The open-access book “Health of People, Health of Planet and Our Responsibility”—which casts global climate change as a public-health crisis—was never meant to just sit on a shelf or in a hard drive.
School of Medicine experts Dr. Susan Little and Dr. Stephen A. Spector share more about how the UC San Diego community can get involved in the latest vaccine trials, when a vaccine may be approved, and how the vaccines are designed to produce antibodies.
Diverse teams across University of California San Diego, with collaborators elsewhere, have received two 5-year grants totaling $14.3 million from the National Institutes of Health (NIH) Common Fund to continue their work as a 4D Nucleome Research Hub and Center.
UC San Diego Health will be a test site for a third, major Phase III clinical trial to assess a vaccine candidate for the novel coronavirus that causes COVID-19. Sponsored by Janssen Pharmaceuticals, the trial will recruit up to 60,000 participants at sites in the United States and worldwide.
Researchers at University of California San Diego School of Medicine, in collaboration with local partners, have been awarded a $5 million grant from the National Institutes of Health (NIH) to implement a program of widespread testing for COVID-19 in San Ysidro.
Researchers at UC San Diego School of Medicine and University of Rome La Sapienza examined middle-aged and older adults in San Diego and Cilento, Italy and found loneliness and wisdom had a strong negative correlation. The wiser the person, the less lonely they were.
A team of researchers in the United States and Japan reports that spinal cord stimulation (SCS) measurably decreased pain and reduced motor symptoms of Parkinson’s disease, both as a singular therapy and as a “salvage therapy” after deep brain stimulation (DBS) therapies were ineffective.
A team led by researchers at University of California San Diego School of Medicine has used artificial intelligence technologies to analyze natural language patterns to discern degrees of loneliness in older adults.
Even as the first wave of the pandemic still roils, fears are rising of a second crush of COVID-19 infections. But because the novel coronavirus is, well, novel, no one can yet say if that will happen. One thing is certain, though, another viral wave is coming: flu season.
Early detection and intervention stanched the first known introductions of the SARS-CoV-2 virus into North America and Europe, validating the effectiveness of quick, comprehensive testing and contact tracing, but inadequate public health measures allowed the virus to take hold.